Migraine Clinical Trials

Showing 201-220 of 467 trials

The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.

NCT05742191

A prospective study that investigates the impact of circadian rhythm disturbances due to daylight saving time transitions on migraine patients. The Primary aim is to investigate the impact of springtime DST (March 12 2023 at 2 AM on Sunday) on sleep metrics in patients with migraine headaches. Secondary aim is to examine the association between incidence of migraine headaches and sleep metrics with time transitions. Participants will be provided with a Withings non-wearable/contactless sleep tracker, which will be placed under the mattress for a period of 4 weeks (2 weeks before and 2 weeks after) during daylight saving time transition in March, 2023. Withings Health Mate app will be downloaded to the participant's smartphone to collect Sleep Data. Headache diaries will be provided to log the details of the migraines during the study period. Morningness - eveningness questionnaire (MEQ) will be used to categorize subjects on the chronotype spectrum.

Episodic Migraine

OSF Healthcare System50 participantsStarted Feb 2023

Peoria, Illinois, United States

COMPLETEDPHASE3

Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine

NCT03303105

To evaluate the long-term safety and tolerability of subcutaneous (SC) administration of TEV-48125 (at 225 mg once monthly \[except for a loading dose of 675 mg for CM patients\] or at 675 mg every 3 months) for the preventive treatment of Chronic Migraine and Episodic Migraine patients

Migraine

Otsuka Pharmaceutical Co., Ltd.50 participantsStarted Dec 2017

Iruma, Japan

COMPLETEDPHASE3

Safety and Efficacy in Adult Subjects With Acute Migraines

NCT03237845

The purpose of this study is to compare the efficacy of BHV-3000 (rimegepant) versus placebo in subjects with Acute Migraines

Migraine, With or Without Aura

Pfizer1,499 participantsStarted Jul 2017

Mobile, Alabama, United States • Glendale, Arizona, United States • Rogers, Arkansas, United States +47 more locations

The Effect of Daylight Saving Time Transitions on Sleep and Migraine Headaches.

Long-term Safety and Tolerability of Subcutaneous Administration of TEV-48125 for the Preventive Treatment of Migraine

Safety and Efficacy in Adult Subjects With Acute Migraines

Related Searches

Hypersensitivity to Phosphodiesterase 5 Inhibition in Post-Traumatic Headache

Digital-technology Based Interventions on Treatment of Migraine.

Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale

Efficacy, Tolerability, and Safety of DFN-15

Use of the Avulux® Lenses as an Aid in Reducing the Impact of Migraine Headaches

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study

Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches

Instrument Based Fascial Abrasion Versus Myofascial Release Technique in Cervicogenic Headache Patients

Tailored Digital Treatment for Migraine

The Effectiveness of Transcranial Direct Current Stimulation as Adjunctive Treatment for Chronic Daily Headache in Systemic Lupus Erythematosus

Sphenopalatine Block Versus Greater Occipital Nerve Block in PDPH

A Study on the Usability of the Needle-free Intraject® System in Adult Patients During Acute Migraine Attack

Probiotics as Adjunctive Migraine Prophylaxis

TBI Care: Collaborative Care for Pain After Traumatic Brain Injury (TBI)

Using the S100B Protein for Emergency Headache Management Care (S100)

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

The Effect of Botulinum Toxin A on Headache Attributed to TMD